Application 018753
- Type
- NDA
- Sponsor
- INTL MEDICATION
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 20MG | No | No |
| 002 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018753-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | ||
| N018753-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018753-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1984-02-28 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018753-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1984-02-28 | 5d02ea3f76ae… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Micro Labs Limited | 2f547f7c-0322-465c-9764-43f955d98ab2 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Henry Schein, Inc. | d8407b0e-7838-4ab6-b9dd-1f7ecf1e0a17 | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Henry Schein, Inc. | a9853417-0442-4f53-9543-e0749bc3c80d | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Henry Schein, Inc. | 15e4c3a3-7d64-471e-bfdf-6156731e24aa | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 668e9f1f-0df0-45f6-8281-f1b98a4a681d | 2026-10-29 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | d75ba8bd-9494-4306-8443-9c1a90992dd5 | 2026-10-26 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 5e37f97b-f5db-23a0-e063-6394a90a9b72 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 5e38ad23-ac84-e936-e063-6394a90ae351 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 48d8f490-e9d1-4c95-ab2f-414d3f4a9df4 | 2026-10-16 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Cardinal Health 107, LLC | 2590ebb6-ce2a-4e23-9244-e54e3010d488 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | c24489c3-65e0-44e3-a50a-8bb0672e8821 | 2026-10-14 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 52e75604-5766-40e8-a13a-8c449e06ebda | 2026-10-14 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 12137a90-fb35-45d7-8984-0b04793d3e34 | 2026-10-14 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Amneal Pharmaceuticals LLC | d5b9f12e-d1e9-42de-90f2-c9ba33a86457 | 2026-09-17 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 571a52ed-5258-46d5-a0d2-9a984cf73895 | 2026-09-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 0b3d986c-eecc-adbe-e063-6294a90a0fb2 | 2026-09-14 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | REMEDYREPACK INC. | ab1a7e16-f746-41af-8faf-b69d3ffd62ba | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | dba00759-87b4-4ecf-998e-ba03ed3d2f1a | 2026-08-17 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Redpharm Drug | 58d2a38d-75f8-dcb9-e063-6294a90a10d7 | 2026-08-12 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | 58cc1e38-6000-1489-e063-6394a90a5978 | 2026-08-11 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.